Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0.00494233937397039 -0.00329489291598031
Stock impact report

TG Therapeutics Announces Data Presentations at the Upcoming 35th Annual Congress of ECTRIMS 

TG Therapeutics, Inc (TGTX)  More Company Research Source: GlobeNewswire
Last tg therapeutics, inc earnings: 11/12 07:34 am Check Earnings Report
US:NASDAQ Investor Relations: ir.tgtherapeutics.com
PDF NEW YORK, Aug. 29, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that abstracts featuring ublituximab, the Company’s novel, glycoengineered anti-CD20 monoclonal antibody, in relapsing forms of multiple sclerosis (RMS) have been accepted for presentation at the upcoming 35th Annual Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), to be held September 11 – 13, 2019 in Stockholm, Sweden. Abstracts are now available online and can be accessed on the ECTRIMS meeting website at www.ectrims-congress.eu. Michael S. Weiss, the Company’s Executive Chairman and Chief Executive Officer stated, “We are extremely pleased to present the first look of demographic data from our ULTIMATE Phase 3 program, as well as continued long term follow up data from our Phase 2 MS trial during ECTRIMS 2019. The final Phase 2 efficacy data demonstrated ublituximab to be efficacious and the long-term safety data continue to demonstrate [Read more]
Impact snapshot Event time: TGTX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
TGTX alerts
from News Quantified
Opt-in for
TGTX alerts

from News Quantified
Opt-in for
TGTX alerts

from News Quantified